A new drug called Olumiant could be hitting the market soon. The FDA has approved the drug for treating people with severe alopecia. Our guests share their experience with the disorder, and their thoughts on the new drug.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Alopecia patients finally have an FDA-approved hair-loss treatmentThe drug, Olumiant, is an oral medication that works by suppressing the autoimmune reaction responsible for hair loss.
Consulte Mais informação »
Tucker: FDA Banning Menthol Cigs Is a ‘War Against Happiness’The Fox host accused the agency of “hassling” Black smokers with its proposal, which experts say could prevent hundreds of thousands of premature deaths
Consulte Mais informação »
FDA advisors approve COVID-19 vaccine shots for kids under 5-years-old -SAN DIEGO (KUSI) – An FDA advisory panel supports COVID-19 vaccines for children six months of age to five years old. With the FDA vaccine chief saying, “there is a troubling surge in children’s hospitalizations during the omicron wave. Children in that age group are the only ones not currently eligible to be vaccinated against COVID-19. All 21 vaccine advisors...
Consulte Mais informação »
Parents react to FDA advisers' vote on children's COVID vaccinationsLaura Hohm, a mother of two young daughters, says the constantly changing goalposts for vaccinating children against COVID-19 has been frustrating.
Consulte Mais informação »
'Finally': Parents react to FDA endorsing COVID vaccines for kids under 5FDA advisers recommend that both Moderna and Pfizer COVID vaccines for kids under 5 be authorized for emergency use. Parents are both angry and relieved.
Consulte Mais informação »
COVID-19 vaccine: FDA authorizes 1st shots for kids under 5; CDC review nextBREAKING: U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week.
Consulte Mais informação »